Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01710085
What this trial is testing

Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer Patients

Who this might be right for
Cervical CancerEndometrial Cancer
Uludag University 100
Not applicableStudy completedNCT02486471
What this trial is testing

Hemostatic Procedure After Biopsy of the Cervix

Who this might be right for
Uterine Cervical Dysplasia
Zydolab - Institute of Cytology and Immune Cytochemistry 166
Not applicableStudy completedNCT02869399
What this trial is testing

Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention

Who this might be right for
Cancer of Head and Neck
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 94
Large-scale testing (Phase 3)Not Yet RecruitingNCT07332221
What this trial is testing

Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial

Who this might be right for
Esophageal Cancer
Henan Cancer Hospital 435
Early research (Phase 1)Ended earlyNCT04249947
What this trial is testing

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Who this might be right for
Prostatic Neoplasms, Castration-ResistantNeoplasms by Histologic TypeNeoplasms, Prostate+14 more
Poseida Therapeutics, Inc. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04340258
What this trial is testing

Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC

Who this might be right for
HNSCC
University of Cincinnati 50
Early research (Phase 1)WithdrawnNCT06357858
What this trial is testing

ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma
Case Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT00929526
What this trial is testing

Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 752
Not applicableLooking for participantsNCT06835426
What this trial is testing

High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

Who this might be right for
Breast CarcinomaProstate Cancer SurgeryThyroid Cancer+10 more
Algemeen Ziekenhuis Maria Middelares 150
Early research (Phase 1)UnknownNCT06225921
What this trial is testing

Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas

Who this might be right for
Esophageal Squamous Cell Carcinoma
West China Hospital 6
Very early researchEnded earlyNCT02827838
What this trial is testing

Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

Who this might be right for
Human Papillomavirus InfectionStage I Oral Cavity Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell Carcinoma+9 more
Wake Forest University Health Sciences 17
Testing effectiveness (Phase 2)Ended earlyNCT02479178
What this trial is testing

BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Urothelial CarcinomaCholangiocarcinomaCervical Cancer+1 more
BIND Therapeutics 73
Not applicableStudy completedNCT03363347
What this trial is testing

BRAF V600E and Redifferentiation Therapy in Radioiodine-refractory Papillary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Heidelberg University 25
Testing effectiveness (Phase 2)WithdrawnNCT04834349
What this trial is testing

Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaUnresectable Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Not applicableUnknownNCT06069648
What this trial is testing

Effects of Decision Aids on the Participation of South Asian Women in Cervical Cancer Screening

Who this might be right for
Cervical Cancer
Chinese University of Hong Kong 270
Early research (Phase 1)Study completedNCT02646748
What this trial is testing

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

Who this might be right for
Colorectal Cancer (CRC)Endometrial CancerMelanoma+8 more
Incyte Corporation 159
Not applicableUnknownNCT04721184
What this trial is testing

Impact of Low Muscle Mass in HNC Treated With Immunotherapy

Who this might be right for
Head and Neck Small Cell CarcinomaSarcopenia
Institut Català d'Oncologia 120
Early research (Phase 1)Study completedNCT01149343
What this trial is testing

Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer

Who this might be right for
Melanoma
GlaxoSmithKline 107
Not applicableStudy completedNCT00507208
What this trial is testing

Dynasplint Therapy for Trismus in Head and Neck Cancer

Who this might be right for
Trismus
University of Alabama at Birmingham 53
Testing effectiveness (Phase 2)Ended earlyNCT03911076
What this trial is testing

Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL

Who this might be right for
ASC-USASC-HLSIL
PapiVax Biotech, Inc. 16
Next Page